세계의 칸나비디올(CBD) 시장 보고서(2025년)

Cannabidiol (CBD) is a chemical compound derived from the Cannabis Sativa plant, known as hemp or cannabis. It is utilized for various health conditions, including epilepsy, anxiety, dystonia, pain, Parkinson's disease, Crohn's disease, and more. Additionally, CBD is incorporated into coffee products, skincare items, and pet treats.

The primary product types of cannabidiol encompass oil, tinctures, suppositories, transdermal patches, vape oil, isolates, creams and roll-ons, capsules, tablets, and other formulations. CBD oil is formulated by extracting CBD from cannabis plants and blending it with a carrier oil like coconut or hemp seed oil. The sources of CBD include marijuana and hemp, utilized in oil and supplement production. Applications span medical, personal use, pharmaceuticals, and wellness, with distribution through channels like hospital pharmacies, retail pharmacies, online stores, and other distribution channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The escalating U.S. tariffs and rising trade tensions in spring 2025 are expected to significantly affect the chemicals sector, which is facing a disproportionate impact-particularly from tariffs on petrochemicals and intermediates, where affordable domestic alternatives are limited. Specialty chemical producers, who rely heavily on Chinese raw materials, are encountering production disruptions. Meanwhile, fertilizer manufacturers are seeing their profit margins squeezed due to tariffs on phosphate imports. In response, companies are increasing investments in R&D for bio-based alternatives, forming procurement alliances to strengthen purchasing power, and relocating production to tariff-neutral countries like Saudi Arabia.

The cannabidiol market research report is one of a series of new reports from The Business Research Company that provides cannabidiol market statistics, including cannabidiol industry global market size, regional shares, competitors with a cannabidiol market share, detailed cannabidiol market segments, market trends and opportunities, and any further data you may need to thrive in the cannabidiol industry. This cannabidiol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cannabidiol market size has grown exponentially in recent years. It will grow from $12.94 billion in 2024 to $17.63 billion in 2025 at a compound annual growth rate (CAGR) of 36.3%. The growth in the historic period can be attributed to changing regulatory environment, leading to increased legalization of cbd, growth in public awareness and acceptance of the potential health benefits of cbd, medical research supporting the use of cbd for various health conditions, emergence of diverse product categories, including cbd-infused foods, beverages, and skincare, and increased availability of cbd products through retail and e-commerce channels.

The cannabidiol market size is expected to see exponential growth in the next few years. It will grow to $57.59 billion in 2029 at a compound annual growth rate (CAGR) of 34.4%. The growth in the forecast period can be attributed to global legalization and regulatory harmonization of cbd products, pharmaceutical research and development for fda-approved cbd medications, increased consumer interest in cbd for mental health and relaxation, expansion of The pet cbd market and veterinary applications, and expansion of The hemp industry for cbd production. Major trends in the forecast period include development of novel cbd delivery methods and formulations, integration of blockchain and traceability solutions in the cbd supply chain, investment in r&d for new cbd-based pharmaceuticals, customized cbd formulations, and novel cbd delivery methods.

The forecast of 34.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US by increasing prices for CBD isolates and extracts, heavily imported from Colombia and Canada.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing market acceptance and utilization of CBD products, fueled by government approvals, are poised to drive the expansion of the cannabidiol market. CBD, derived from Cannabis Sativa, serves as a key ingredient in various consumer products and therapeutic applications. Recognizing the potential health benefits, governments worldwide are taking measures to improve regulatory pathways for the lawful marketing of CBD products, contributing to the market's growth. An illustrative example is the Therapeutic Goods Administration in Australia, which, in January 2022, approved approximately 210,000 SAS Category B applications for unapproved medicinal cannabis products.

The anticipated rise in neurological disorders is set to be a significant driver for the cannabidiol market. Neurological disorders affecting the central and peripheral nervous systems, including the brain and spinal cord, are increasingly prevalent. Cannabis has shown promise in treating neurological conditions by regulating calcium homeostasis and reducing neuroinflammation. As reported by the Parkinson's Foundation in December 2022, the incidence rate of Parkinson's disease in the United States surged to nearly 90,000 diagnoses annually, a notable increase from previous estimates of 60,000 yearly diagnoses.

Major companies in the cannabidiol market are concentrating on product innovation, particularly in developing non-psychotropic options that do not produce psychoactive effects. Non-psychotropic refers to substances that do not influence mental processes or alter consciousness, making them suitable for medicinal use without inducing a high. For example, in January 2024, Akumentis Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Clasepi for epilepsy treatment. This new DCGI-approved prescription cannabidiol was introduced in India to help manage seizures related to Lennox-Gastaut syndrome, Dravet syndrome, and Tuberous Sclerosis Complex in patients aged one year and older. This synthetic CBD product contains less than 0.1% THC, ensuring it is non-psychotropic. Clinical studies have shown its effectiveness in reducing seizures, especially when traditional antiseizure medications fail.

Major companies in the cannabidiol market are forming strategic partnerships to broaden their product offerings, enhance research and development capabilities, and strengthen their market presence. This approach allows them to provide essential communication services to individuals, businesses, and governments. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutual benefits and success. For example, in February 2024, dsm-firmenich, a Netherlands-based chemical manufacturing company, teamed up with Zerion Pharma, a Denmark-based pharmaceutical firm. Through this collaboration, they aim to develop innovative solutions that combine DSM-Firmenich's expertise in advanced materials and formulations with Zerion Pharma's strengths in pharmaceutical development.

In December 2022, Prima, a US-based health and personal care products company, acquired Prospect Farms for an undisclosed amount. This acquisition is intended to enhance its product offerings and expand its market presence. This strategic move will incorporate Prospect Farms' expertise in high-quality hemp-derived products, reinforcing Prima's commitment to wellness and sustainability. Prospect Farms is a US-based health and wellness brand that specializes in hemp-derived products.

Major companies operating in the cannabidiol market include Endoca BV, Cannoid LLC, Medical Marijuana Inc., Folium Biosciences, Elixinol Global Limited, NuLeaf Naturals LLC, Isodiol International Inc., Pharmahemp d.o.o., Canopy Growth Corp., CV Sciences Inc., Medterra LLC, Cronos Group, CBD American Shaman LLC, Walgreens Boots Alliance, Aphria Inc., Maricann Inc., Tilray Inc., Organigram Holding Inc., CannTrust Holdings Company, Charlotte's Web Holdings Inc., Aurora Cannabis Inc., GW Pharmaceuticals PLC, Green Roads, HempMeds PX LLC, Eco Sciences, Bluebird Botanicals, HempFusion Inc., Kannaway LLC, Lazarus Naturals, Kazmira LLC, HempLife Today LLC

North America was the largest region in the cannabidiol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabidiol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the cannabidiol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The cannabidiol market consists of sales of full spectrum CBD, broad spectrum CBD and CBD isolate forms of cannabidiol products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cannabidiol Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cannabidiol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cannabidiol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cannabidiol market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Oil; Tinctures; Suppository; Transdermal Patches; Vape Oil; Isolates; Creams and Roll-on; Capsules; Tablet; Other Products
• 2) By Source: Marijuana; Hemp
• 3) By Treatment: CBD Oil; Supplements
• 4) By Application: Medical; Personal Use; Pharmaceuticals; Wellness
• 5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores; Other Distribution Channels
• Subsegments:
• 1) By Oil: Full-Spectrum CBD Oil; Broad-Spectrum CBD Oil; CBD Isolate Oil
• 2) By Tinctures: CBD Tinctures with Flavoring; Unflavored CBD Tinctures
• 3) By Suppository: Rectal Suppositories; Vaginal Suppositories
• 4) By Transdermal Patches: CBD Patches for Pain Relief; CBD Patches for Sleep
• 5) By Vape Oil: CBD Vape Cartridges; CBD Vape Juice
• 6) By Isolates: CBD Powder; CBD Crystals
• 7) By Creams and Roll-on: Topical CBD Creams; CBD Roll-on Gels
• 8) By Capsules: Softgel Capsules; Hard Capsules
• 9) By Tablet: CBD Tablets; CBD Chewable Tablets
• 10) By Other Products: Gummies; Beverages; Edibles
• Companies Mentioned: Endoca BV; Cannoid LLC; Medical Marijuana Inc.; Folium Biosciences; Elixinol Global Limited; NuLeaf Naturals LLC; Isodiol International Inc.; Pharmahemp d.o.o.; Canopy Growth Corp.; CV Sciences Inc.; Medterra LLC; Cronos Group; CBD American Shaman LLC; Walgreens Boots Alliance; Aphria Inc.; Maricann Inc.; Tilray Inc.; Organigram Holding Inc.; CannTrust Holdings Company; Charlotte's Web Holdings Inc.; Aurora Cannabis Inc.; GW Pharmaceuticals PLC; Green Roads; HempMeds PX LLC; Eco Sciences; Bluebird Botanicals; HempFusion Inc.; Kannaway LLC; Lazarus Naturals; Kazmira LLC; HempLife Today LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cannabidiol Market Characteristics

3. Cannabidiol Market Trends And Strategies

4. Cannabidiol Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cannabidiol Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cannabidiol PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cannabidiol Market Growth Rate Analysis
• 5.4. Global Cannabidiol Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cannabidiol Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cannabidiol Total Addressable Market (TAM)

6. Cannabidiol Market Segmentation

• 6.1. Global Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oil
• Tinctures
• Suppository
• Transdermal Patches
• Vape Oil
• Isolates
• Creams and Roll-on
• Capsules
• Tablet
• Other Products
• 6.2. Global Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Marijuana
• Hemp
• 6.3. Global Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBD Oil
• Supplements
• 6.4. Global Cannabidiol Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical
• Personal Use
• Pharmaceuticals
• Wellness
• 6.5. Global Cannabidiol Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Other Distribution Channels
• 6.6. Global Cannabidiol Market, Sub-Segmentation Of Oil, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Full-Spectrum CBD Oil
• Broad-Spectrum CBD Oil
• CBD Isolate Oil
• 6.7. Global Cannabidiol Market, Sub-Segmentation Of Tinctures, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBD Tinctures with Flavoring
• Unflavored CBD Tinctures
• 6.8. Global Cannabidiol Market, Sub-Segmentation Of Suppository, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rectal Suppositories
• Vaginal Suppositories
• 6.9. Global Cannabidiol Market, Sub-Segmentation Of Transdermal Patches, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBD Patches for Pain Relief
• CBD Patches for Sleep
• 6.10. Global Cannabidiol Market, Sub-Segmentation Of Vape Oil, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBD Vape Cartridges
• CBD Vape Juice
• 6.11. Global Cannabidiol Market, Sub-Segmentation Of Isolates, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBD Powder
• CBD Crystals
• 6.12. Global Cannabidiol Market, Sub-Segmentation Of Creams and Roll-on, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical CBD Creams
• CBD Roll-on Gels
• 6.13. Global Cannabidiol Market, Sub-Segmentation Of Capsules, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Softgel Capsules
• Hard Capsules
• 6.14. Global Cannabidiol Market, Sub-Segmentation Of Tablet, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CBD Tablets
• CBD Chewable Tablets
• 6.15. Global Cannabidiol Market, Sub-Segmentation Of Other Products, By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gummies
• Beverages
• Edibles

7. Cannabidiol Market Regional And Country Analysis

• 7.1. Global Cannabidiol Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cannabidiol Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cannabidiol Market

• 8.1. Asia-Pacific Cannabidiol Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cannabidiol Market

• 9.1. China Cannabidiol Market Overview
• 9.2. China Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cannabidiol Market

• 10.1. India Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cannabidiol Market

• 11.1. Japan Cannabidiol Market Overview
• 11.2. Japan Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cannabidiol Market

• 12.1. Australia Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cannabidiol Market

• 13.1. Indonesia Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cannabidiol Market

• 14.1. South Korea Cannabidiol Market Overview
• 14.2. South Korea Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cannabidiol Market

• 15.1. Western Europe Cannabidiol Market Overview
• 15.2. Western Europe Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cannabidiol Market

• 16.1. UK Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cannabidiol Market

• 17.1. Germany Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cannabidiol Market

• 18.1. France Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cannabidiol Market

• 19.1. Italy Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cannabidiol Market

• 20.1. Spain Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cannabidiol Market

• 21.1. Eastern Europe Cannabidiol Market Overview
• 21.2. Eastern Europe Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cannabidiol Market

• 22.1. Russia Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cannabidiol Market

• 23.1. North America Cannabidiol Market Overview
• 23.2. North America Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cannabidiol Market

• 24.1. USA Cannabidiol Market Overview
• 24.2. USA Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cannabidiol Market

• 25.1. Canada Cannabidiol Market Overview
• 25.2. Canada Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cannabidiol Market

• 26.1. South America Cannabidiol Market Overview
• 26.2. South America Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cannabidiol Market

• 27.1. Brazil Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cannabidiol Market

• 28.1. Middle East Cannabidiol Market Overview
• 28.2. Middle East Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cannabidiol Market

• 29.1. Africa Cannabidiol Market Overview
• 29.2. Africa Cannabidiol Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cannabidiol Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cannabidiol Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cannabidiol Market Competitive Landscape And Company Profiles

• 30.1. Cannabidiol Market Competitive Landscape
• 30.2. Cannabidiol Market Company Profiles
  • 30.2.1. Endoca BV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Cannoid LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medical Marijuana Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Folium Biosciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Elixinol Global Limited Overview, Products and Services, Strategy and Financial Analysis

31. Cannabidiol Market Other Major And Innovative Companies

• 31.1. NuLeaf Naturals LLC
• 31.2. Isodiol International Inc.
• 31.3. Pharmahemp d.o.o.
• 31.4. Canopy Growth Corp.
• 31.5. CV Sciences Inc.
• 31.6. Medterra LLC
• 31.7. Cronos Group
• 31.8. CBD American Shaman LLC
• 31.9. Walgreens Boots Alliance
• 31.10. Aphria Inc.
• 31.11. Maricann Inc.
• 31.12. Tilray Inc.
• 31.13. Organigram Holding Inc.
• 31.14. CannTrust Holdings Company
• 31.15. Charlotte's Web Holdings Inc.

32. Global Cannabidiol Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cannabidiol Market

34. Recent Developments In The Cannabidiol Market

35. Cannabidiol Market High Potential Countries, Segments and Strategies

• 35.1 Cannabidiol Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cannabidiol Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cannabidiol Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer